ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.13202G>A (p.Arg4401Gln)

gnomAD frequency: 0.00133  dbSNP: rs200431386
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000041104 SCV000064795 likely benign not specified 2012-01-24 criteria provided, single submitter clinical testing Arg4163Gln in exon 45B of TTN: This variant is not expected to have clinical sig nificance because it has been identified in 0.5% (15/3002) of African American c hromosomes by the NHLBI Exome Sequencing Project in a broad population (http://e vs.gs.washington.edu/EVS). Arg4163Gln in exon 45B of TTN (allele frequency = 0. 5%, 15/3002) **
GeneDx RCV001719779 SCV000238182 likely benign not provided 2021-04-29 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 25363768)
Ambry Genetics RCV000246916 SCV000320095 likely benign Cardiovascular phenotype 2018-08-14 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Eurofins Ntd Llc (ga) RCV000041104 SCV000333898 likely benign not specified 2015-08-21 criteria provided, single submitter clinical testing
Invitae RCV000469656 SCV000555648 benign Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2024-01-29 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000041104 SCV000615992 benign not specified 2016-10-28 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001719779 SCV002049662 likely benign not provided 2021-07-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839829 SCV002100800 benign Autosomal recessive limb-girdle muscular dystrophy type 2J 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839830 SCV002100801 benign Myopathy, myofibrillar, 9, with early respiratory failure 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839831 SCV002100802 benign Early-onset myopathy with fatal cardiomyopathy 2021-09-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001839828 SCV002100803 benign Tibial muscular dystrophy 2021-09-10 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003904983 SCV004721716 likely benign TTN-related condition 2020-01-27 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Clinical Genetics, Academic Medical Center RCV000041104 SCV001979013 benign not specified no assertion criteria provided clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV001719779 SCV001979839 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.